Table 2.
Descriptive and correlational data for toolbox, BRIEF2, and clinical measures.
| Descriptive Data | Correlation to Toolbox | ||||||
|---|---|---|---|---|---|---|---|
| n | Mean (SD) | GDS (SD) | Impairment/Elevated | Flanker | LSWMT | DCCST | |
| Toolbox: Flanker | 105 | 87.41 (13.75) | .89 (1.17) | 48.6% | - | - | - |
| Toolbox: LSWMT | 100 | 94.19 (15.35) | .52 (1.01) | 28% | .177 | - | - |
| Toolbox: DCCST | 105 | 91.91 (13.12) | .52 (1.06) | 26.7% | .422** | .231* | - |
| NEPSY-II: Inhibition | 91 | 7.42 (3.27) | .90 (1.14) | 45.1% | .332** | −.048 | .206 |
| NEPSY-II: Switching | 57 | 7.86 (3.28) | .58 (1.12) | 28.1% | .288* | .305* | .406** |
| Wechsler: WMI | 48 | 88.92 (16.09) | .81 (1.30) | 35.4% | .308* | .403** | .381** |
| BRIEF2-Inhibit | 60 | 67.32 (12.83) | 2.2 (1.78) | 73.3% | −.070 | .131 | −.160 |
| BRIEF2-WM | 60 | 69.70 (8.90) | 2.4 (1.63) | 85% | −.149 | .000 | .227 |
| BRIEF2-Shift | 60 | 65.85 (13.39) | 2.1 (1.86) | 66.7% | .146 | −.013 | −.020 |
| CDI-2: Total | 56 | 57.30 (13.77) | - | 39.3% | .180 | −.012 | .005 |
| SCARED: Total (raw) | 54 | 25.37 (15.06) | - | 48.4% | .079 | −.033 | .026 |
| BASC-3: Anxiety (parent) | 89 | 59.24 (12.05) | - | 47.2% | .257* | −.071 | −.001 |
| BASC-3: Depression (parent) | 89 | 62.36 (13.64) | - | 39.3% | .151 | −.148 | −.008 |
Impairment: < 1 standard deviation below mean for performance-based EF, > 1 standard deviation above mean for rater-based EF; clinically elevated symptoms: ≥ 60 for CDI-2/BASC-3 and ≥ 25 for SCARED.